Cargando…

Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index

Detalles Bibliográficos
Autor principal: Altundag, Kadri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300564/
https://www.ncbi.nlm.nih.gov/pubmed/36894371
http://dx.doi.org/10.1016/j.breast.2023.03.003
_version_ 1785064613951307776
author Altundag, Kadri
author_facet Altundag, Kadri
author_sort Altundag, Kadri
collection PubMed
description
format Online
Article
Text
id pubmed-10300564
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103005642023-06-29 Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index Altundag, Kadri Breast Correspondence Elsevier 2023-03-07 /pmc/articles/PMC10300564/ /pubmed/36894371 http://dx.doi.org/10.1016/j.breast.2023.03.003 Text en © 2023 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Altundag, Kadri
Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title_full Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title_fullStr Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title_full_unstemmed Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title_short Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
title_sort indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300564/
https://www.ncbi.nlm.nih.gov/pubmed/36894371
http://dx.doi.org/10.1016/j.breast.2023.03.003
work_keys_str_mv AT altundagkadri indolenttriplenegativebreastcancerpatientsaremorelikelytodeveloplaterelapsecomparedtotriplenegativebreastcancerpatientswithahighproliferationindex